IGF1 and myocardial infarction: Therefore, the present study aimed to investigate the association of IGF-1 serum levels at hospital admission with mortality and recurrent non-fatal myocardial infarctions in hyperglycemic non-insulin dependent ACS patients who participated in the BIOMArCS-2 trial and were followed for 5 years.